TrialInfection2025

Efficacy of tocilizumab for hospitalized patients with COVID-19 pneumonia and high IL-6 levels: A randomized controlled trial.

Júlia Sellarès-Nadal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.